No abstract available.
Xu C, Xie Y, Xie P, Li J, Tong Z, Yang Y. ZDHHC9: a promising therapeutic target for triple-negative breast cancer through immune modulation and immune checkpoint blockade resistance. Discover oncology. 2023 Oct 24;14(1):191
PMID: 0
View Full Text